Form 4: OSI Systems Executive Boosts Stake with RSU Grant

W. Paul Constantine, President of Spacelabs Healthcare at OSI Systems Inc., acquired 470 shares of common stock through a Restricted Stock Unit grant valued at $266.17 per share, increasing his direct beneficial ownership to 1,394 shares.

Summary

• W. Paul Constantine, President of Spacelabs Healthcare at OSI Systems Inc. (OSIS), reported an acquisition of company stock.
• The transaction involved the acquisition of 470 shares of Common Stock on December 2, 2025.
• The acquisition price for these shares was $266.17 per share.
• Following this transaction, Mr. Constantine directly beneficially owns 1,394 shares of OSI Systems Inc. Common Stock.
• The acquired shares are Restricted Stock Units (RSUs), which will vest at 25% annually over four years, contingent upon Mr. Constantine's continued employment with the Issuer.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, particularly through an RSU grant, is generally viewed positively as it aligns management's interests with long-term shareholder value and indicates confidence in the company's future prospects.

Positives

• Increased direct beneficial ownership by a key executive, W. Paul Constantine, potentially signaling confidence in the company's future performance and strategic direction.
• The acquisition is structured as a Restricted Stock Unit (RSU) grant, which aligns executive incentives with long-term shareholder value creation as vesting is tied to continued employment and future stock performance.

Risks

• The vesting of the 470 Restricted Stock Units (RSUs) is subject to the Reporting Person's continued employment with OSI Systems Inc. over the four-year vesting period.

Future Outlook

The acquired Restricted Stock Units (RSUs) are scheduled to vest at 25% annually over four years, starting from the grant date of December 2, 2025, subject to the executive's continued employment.

Industry Context

This Form 4 filing is a standard disclosure of an insider transaction, specifically an executive's acquisition of company stock through a Restricted Stock Unit (RSU) grant. Such grants are common in executive compensation packages across various industries, aiming to align management's interests with long-term shareholder value. The healthcare technology sector, where Spacelabs Healthcare operates, frequently utilizes such equity incentives.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with shareholder value through equity ownership.
• Employees: Standard executive compensation practices may reinforce company stability and long-term vision.

Next Steps

• Annual vesting of 25% of the 470 Restricted Stock Units over the next four years, commencing December 2, 2025.

Key Dates

Keywords

OSI Systems, OSIS, Form 4, Insider Transaction, Restricted Stock Units, RSU, Executive Compensation, Stock Acquisition, Spacelabs Healthcare, Paul Constantine